Condition: Respiratory Viral Infection · Sponsor: SynAct Pharma Aps
A clinical study to evaluate the efficacy and safety of once daily oral dosing of 100 mg AP1189 or placebo administered for 14 days, as an add-on to standard of care (SOC) in participants with respiratory insufficiency expected to be caused by respiratory viral infection.
This description comes directly from the study's public registry record.
Thomas Jonassen, MD · +45 4015 6669 · tj@synactpharma.com
Always discuss trial participation with your own doctor first.
| University Clinical Hospital Mostar, Clinic for Infectious Diseases | Mostar, Herzegovina-Neretva Canton, Bosnia and Herzegovina | Recruiting |
| University Clinical Center Republic of Srpska, Clinic for Infectious Diseases | Banja Luka, Republika Srpska, Bosnia and Herzegovina | Recruiting |
| University Clinical Centre Sarajevo, Clinic for Infectious Diseases | Sarajevo, Sarajevo Canton, Bosnia and Herzegovina | Recruiting |
| Clinical Center of Montenegro, Clinic for Infectious Diseases | Podgorica, Podgorica Municipality, Montenegro | Recruiting |
| Te Toka Tumai Auckland, Auckland City Hospital | Auckland, New Zealand | Recruiting |
| Aotearoa Clinical Trial Trust, Esme Green Building, Middlemore Hospital | Auckland, New Zealand | Recruiting |
| Christchurch Hospital, 2 Riccarton Avenue, | Christchurch, New Zealand | Not Yet Recruiting |
| MRINZ, 7 CSB Building, Wellington Hospital | Wellington, New Zealand | Recruiting |
| University Clinical Centre Nis, Clinic for Infectious Diseases | Niš, Nišava District, Serbia | Recruiting |
| Health Center Uzice, General Hospital Uzice | Užice, Zlatibor District, Serbia | Recruiting |
| University Clinical Centre of Serbia, Clinic for Infectious Diseases | Belgrade, Serbia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07633288